June Sherie Almenoff - Insider Trading & Ownership

Location
C/O Brainstorm Cell Therapeutics Inc., 1325 Avenue Of Americas 28 Th Floor, New York, NY
Summary
The estimated net worth of June Sherie Almenoff is at least $706K dollars as of November 20, 2025. June Sherie Almenoff is the Director of TENAX THERAPEUTICS, INC. and owns shares of TENAX THERAPEUTICS, INC. (TENX) stock worth about $593K. June Sherie Almenoff is the Director of Avalo Therapeutics, Inc. and owns shares of Avalo Therapeutics, Inc. (AVTX) stock worth about $88.8K. June Sherie Almenoff is the Director of BRAINSTORM CELL THERAPEUTICS INC. and owns shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI) stock worth about $23.4K.
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of June Sherie Almenoff

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TENX TENAX THERAPEUTICS, INC. Director $593K +$14.9K +2.58% Nov 17, 2025
AVTX Avalo Therapeutics, Inc. Director $88.8K Jun 17, 2025
BCLI BRAINSTORM CELL THERAPEUTICS INC. Director $23.4K Dec 15, 2021
ATNM Actinium Pharmaceuticals, Inc. Director Mar 31, 2025

Insider Transactions Reported by June Sherie Almenoff:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.